1.85 USD
↘ 0.08 (4.15%)AT CLOSE (03:59 PM EDT)
XBiotech Inc
XBITNASDAQ • USD
1.89
↗ 0.04 (2.22%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
1.89
↗ 0.04 (2.22%)
Market: CLOSED
Shares of XBiotech Inc (XBIT) are trading at $1.82. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, XBIT appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 26, 2026.
Open?$1.92
High?$1.93
Low?$1.82
Prev. Close?$1.93
Volume?136.3K
Avg. Volume?55.2K
VWAP?$1.86
Rel. Volume?2.47x
Bid / Ask
Bid?$1.59 × 100
Ask?$2.22 × 100
Spread?$0.63
Midpoint?$1.91
Valuation & Ratios
Market Cap?58.8M
Shares Out?30.5M
Float?16.6M
Float %?54.3%
P/E Ratio?N/A
P/B Ratio?0.46
EPS?-$1.48
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Themes
Employees
87
Market Cap
58.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-04-15
Address
5217 WINNEBAGO LANE
AUSTIN, TX 78744
Phone: 512-386-2900
AUSTIN, TX 78744
Phone: 512-386-2900
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?98
Momentum?23
Short Sent.?76
Piotroski F-Score?0/9Weak
Altman Z-Score?5.02Safe
Confidence?43%Low
Short InterestHigh
Short % of Float?1.82%Low
Short Interest?300.9K
Days to Cover?6.5
Free Float16.6M
Avg Daily Volume46.4K
Settlement Date2026-10-15
Financial Health
Current Ratio?33.15Strong
Quick Ratio?33.15Strong
Cash Ratio?32.67Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.46CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?1.1CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-35.1%WEAK▾
S&P5
ROA?-33.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-40839000
Enterprise Value?$-50686679
Fundamentals ratios updated end of day